Home > Insider Trading > Bioage Labs Inc. > Profile

Bioage Labs Inc. (BIOA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

Sector: Pharmaceutical Preparations

Related Insiders

Rekha Hemrajani, , 2025-06-09
James Healy, , 2025-06-09
G Patrick Enright, , 2025-06-09

Rekha Hemrajani, , 2025-06-09
James Healy, , 2025-06-09
G Patrick Enright, , 2025-06-09
H. Michael Davidson, , 2025-06-09
Pierre Jean Garnier, , 2025-06-09
Shane Barton, Principal Accounting Officer, 2025-03-10
Eric Morgen, Chief Operating Officer, 2025-02-25
D Paul Rubin, Chief Medical Officer, 2025-02-20
Md A Dov Goldstein, Chief Financial Officer, 2025-02-20
Kristen Fortney, Chief Executive Officer, 2025-02-20
Satyanand Vijay Pande, , 2024-10-03
Cormorant Asset Management, Lp, , 2024-10-01
Bihua Chen, , 2024-10-01
Cormorant Private Healthcare Fund Iv Lp, , 2024-10-01
Cormorant Private Healthcare Fund V Lp, , 2024-10-01

Show All Insiders (15)

Insider Trading: Purchases See All

Insider	Price	Amount	Total Value	Remaining Holdings	Date	Form 4
Hemrajani	$18.00	3,000	$54,000.00	3,000	2024-09-27	Filing
Barton	$18.00	2,632	$47,376.00	2,632	2024-09-27	Filing
Pande	$19.90	25,306	$503,589.40	1,119,195	2024-10-03	Filing
Pande	$19.73	67,096	$1,323,804.08	1,093,889	2024-10-02	Filing
Pande	$19.73	126,793	$2,501,625.89	1,026,793	2024-10-01	Filing

News See All

BioAge Labs, Inc. (BIOA)’s BGE-102 Shows Potent Weight Loss, Plans IND Submission Mid-2025

BioAge Labs, Inc. (NASDAQ:BIOA), a clinical-stage biotech innovator, announced today the completion of IND-enabling studies for its groundbreaking oral NLRP3 inhibitor, BGE-102, targeting obesity.

Keep Reading →

May 29th, 2025 - News

BioAge Labs, Inc. (BIOA): A Bull Case Theory

We came across a bullish thesis on BioAge Labs, Inc. (BIOA) on Substack by Ragnarok Research. In this article, we will summarize the bulls’ thesis on BIOA. BioAge Labs, Inc.

Keep Reading →

April 21st, 2025 - News Stock Analysis

BioAge Labs, Inc. (BIOA): A Bull Case Theory

We came across a bullish thesis on BioAge Labs, Inc. (NASDAQ:BIOA) on Value Investing Subreddit Page by value1024. In this article, we will summarize the bulls’ thesis on BIOA. BioAge Labs, Inc.

Keep Reading →

December 27th, 2024 - News Stock Analysis

10 Best All-Time Low Stocks To Buy Right Now

With November coming to a close, while markets are focused on the future of artificial intelligence and the degree of profitability that AI firms can extract from their multi-billion dollar investments...

Keep Reading →

December 4th, 2024 - Hedge Funds News

13G Filing: Sabby Capital and Bioamber Inc. (BIOA)

Bioamber Inc. (NYSE:BIOA): Hal Mintz's Sabby Capital filed an amended 13D. You can check out Sabby Capital's latest holdings and filings here.

Keep Reading →

September 12th, 2017 - Hedge Funds

Bioamber Inc (BIOA): How It Stacks Up Against Its Peers

It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.

Keep Reading →

December 14th, 2016 - Hedge Funds News

What's the Deal With These Stocks Getting Pounded?

It's been a Friday to forget for many bullish investors as the NASDAQ index opened in the red and continues to decline in late morning trading as valuation worries and concerns about the global economy...

Keep Reading →

January 15th, 2016 - Market Movers News